Live Quote · NASDAQPTGXHealthcare· Biotechnology

Protagonist Therapeutics, Inc.

$121.40▼ 2.11%($-2.62)
MKT CAP $7.92BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
61/100
▌ Mixed
52
Valuation
100
Profitability
10
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTGX research report →

Analyst Price Target
$175.33+44.4% vs. today

Range $160 – $190

Analyst RatingBuy
26 Buy0 Hold0 Sell

Price Chart

+45.75% · this period
$158.62$119.18$79.73Nov 20May 26Nov 20
52-Week Range53% of range
Low
$77.00
Current
$121.40
High
$160.81